| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.00039 | 1 |